EUVIMEDExplore EUVIMED
Open access · CC BY 4.0

A novel long noncoding RNA (lncRNA), LINC02657(LASTR), is a prognostic biomarker associated with immune infiltrates of lung adenocarcinoma based on unsupervised cluster analysis

Fanming Kong, Xinyu Yang, Zhichao Lu, Zongheng Liu, Yang Yang, Ziheng Wang

PeerJ · 2023

DOI: 10.7717/peerj.16167 ↗

At a glance

Journal article in PeerJ, 2023. Written by Fanming Kong and 5 co-authors. Institution: Department of Oncology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China. Major MEDLINE topics: RNA, Long Noncoding, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Adenocarcinoma. Cited 5 times so far (Crossref); 19 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliographic detailsCiteRelated studies

Abstract (original language)

Non-small cell lung cancer (NSCLC) has long been the deadliest malignancy worldwide, with adenocarcinoma (AD) being the most common pathological subtype. Here we focused on the value of LASTR in LUAD. Using expression analysis, enrichment analysis, immune cell infraction analysis, we found that the expression level of LASTR was significantly increased in LUAD tissue. Meanwhile, LASTR was significantly associated with differential infiltration of various immune cells. Kaplan-Meier survival analysis showed that LUAD related with a poor prognosis in terms of OS, PFI, and DSS compared with high-expression LASTR. The enrichment analysis showed that LASTR is related to the pathays like PI3K-AKT signaling pathway. Thus, the present findings could be helpful in a better understand of LASTR in LUAD. RT-PCR was used to verify the high expression of LASTR in LUAD tissues, and the apoptosis of LUAD cell lines was promoted by CCK8 and Transwell experiments to verify the ability of LASTR to promote the migration and invasion of lung cancer cells in vitro .

Subjects

MeSH terms (MEDLINE)

RNA, Long NoncodingCarcinoma, Non-Small-Cell LungLung NeoplasmsAdenocarcinomaHumansPhosphatidylinositol 3-KinasesPrognosisCluster AnalysisBiomarkers

Author keywords

BioinformaticsLASTRLUADOnclogy

Substances

RNA, Long NoncodingPhosphatidylinositol 3-KinasesBiomarkers

Authors and institutions

  • Department of Oncology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China.
  • Department of Trauma Center, Affiliated Hospital of Nantong University, Jiangsu, China.
  • Department of Clinical Bio-bank, Affiliated Hospital of Nantong University, Jiangsu, China.
  • Centre for Precision Medicine Research and Training, Faculty of Health Sciences, University of Macau, Macau SAR, China.

Cite

APA

Kong, F., Yang, X., Lu, Z., Liu, Z., Yang, Y., & Wang, Z. (2023). A novel long noncoding RNA (lncRNA), LINC02657(LASTR), is a prognostic biomarker associated with immune infiltrates of lung adenocarcinoma based on unsupervised cluster analysis. PeerJ. https://doi.org/10.7717/peerj.16167

Vancouver

Kong F, Yang X, Lu Z, Liu Z, Yang Y, Wang Z. A novel long noncoding RNA (lncRNA), LINC02657(LASTR), is a prognostic biomarker associated with immune infiltrates of lung adenocarcinoma based on unsupervised cluster analysis. PeerJ. 2023. doi:10.7717/peerj.16167

BibTeX
@article{Kong2023,
  author = {Kong, Fanming and Yang, Xinyu and Lu, Zhichao and Liu, Zongheng and Yang, Yang and Wang, Ziheng},
  title = {A novel long noncoding RNA (lncRNA), LINC02657(LASTR), is a prognostic biomarker associated with immune infiltrates of lung adenocarcinoma based on unsupervised cluster analysis},
  journal = {PeerJ},
  year = {2023},
  doi = {10.7717/peerj.16167}
}
Start for free →